• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    John Booth to Retire as CEO of Spineology Inc.

    11/9/23 9:00:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care
    Get the next $ATEC alert in real time by email

    Brian Snider Appointed New CEO

    Spineology Inc. ("Spineology" or the "Company"), the leader in ultra-minimally invasive spine surgery, announced today that John Booth will retire from his role as Chief Executive Officer of Spineology, effective November 10, 2023. The Board of Directors has selected Brian Snider as its next Chief Executive Officer, effective November 13, 2023. Mr. Booth will remain with Spineology through 2024, serving in an advisory role to facilitate a smooth transition. Mr. Booth will also resign from the Board of Directors, and the Board has nominated Mr. Snider as a Director.

    Snider joins Spineology with nearly twenty years of progressive leadership experience in the medical device industry. Most recently he served as Executive Vice President of Marketing for Alphatec Spine (NASDAQ:ATEC), as a member of the executive leadership team that was responsible for growing the company's market capitalization from $20M to over $1.2B. During his tenure with ATEC, he had accountability for a variety of disciplines in marketing and product development. Most recently, he was responsible for the Biologics, Cervical, and Thoracolumbar business units. Prior to ATEC, Snider spent nine years at NuVasive, Inc., a leader in innovative products and procedures for minimally disruptive spine surgery. During his tenure at NuVasive, Snider held senior level marketing positions in the Thoracolumbar business segment including the flagship procedure, XLIF®. Mr. Snider received his BBA in Marketing and Information Systems from George Washington University and his MBA from the Fuqua School of Business at Duke University.

    "It has been a great privilege to work with a talented and passionate group of employees throughout the Company, who together have advanced the field of ultra-minimally invasive spine surgery significantly over the Company's history," said John Booth. "I have every confidence that the Company will continue to grow and provide disruptive solutions under Brian's leadership as the next CEO of Spineology."

    Ed Spencer, Chairman of the Board of Spineology, expressed thanks for Booth's leadership. "On behalf of the Board of Directors, our employees, and Spineology's stockholders, I express my deep gratitude to John for his success in leading the Company, as well as for his service as a Spineology Board member for over 20 years."

    "As we prepared for John's retirement, the Board unanimously agreed that Brian Snider was well suited to lead Spineology," continued Spencer. "His years of experience in growing evolutionary companies in the minimally invasive spine market will enable him to immediately contribute to Spineology's continued success."

    "I am thrilled to join the Spineology team," said Snider. "Spineology is a company with a unique procedural foundation that is backed with strong clinical data. I am confident that we will deliver growth and surgical advancement during this next phase. I would like to thank the Board for the opportunity to serve the Spineology team, the shareholders, and most importantly, our patients."

    About Spineology:

    Spineology Inc. leads the way in ultra-minimally invasive spine surgery, revolutionizing how spine surgeons treat and heal back pain. Our proprietary Mesh technology sets us apart from traditional fusion procedures enabling surgeons to optimize outcomes while minimizing tissue disruption and enhancing patient recovery. With a strong commitment to patient-centered care and enabling disruptive technologies, Spineology continues to push the boundaries of what is possible in spine surgery today with the tools of tomorrow.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20231109450171/en/

    Get the next $ATEC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATEC

    DatePrice TargetRatingAnalyst
    10/28/2025$20.00Buy
    Stifel
    10/24/2025$19.00Overweight
    Analyst
    6/16/2025$18.00Buy
    Lake Street
    8/1/2024Overweight → Equal-Weight
    Morgan Stanley
    7/8/2024$19.00Overweight
    Barclays
    2/9/2024$26.00Overweight
    Wells Fargo
    12/19/2023$16.00 → $18.00Buy
    Needham
    10/20/2023$22.00Buy
    ROTH MKM
    More analyst ratings

    $ATEC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ATEC Mourns Passing of Board Member Jeffrey P. Rydin

    Alphatec Holdings, Inc. (NASDAQ:ATEC) ("ATEC"), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced with great sadness that Jeffrey P. Rydin, a valued member of its Board of Directors, has passed away at age 59, following a lengthy illness. Mr. Rydin enjoyed nearly three decades of experience in the medical device and healthcare industries, including senior sales leadership roles at Ellipse Technologies, Inc., NuVasive, Inc., and DePuy Spine, Inc. He was one of the earliest to join the ATEC turnaround effort, coming to the Company as a Special Advisor to the Board in September 2016, in which capacity he drove many of the early deci

    11/7/25 9:05:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    ATEC Reports Third Quarter 2025 Financial Results And Raises Full-Year Guidance

    Total revenue grew $46 million or 30% to $197 million Surgical revenue grew 31% to $177 million Full-year revenue and profitability guidance increased Alphatec Holdings, Inc. (NASDAQ:ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended September 30, 2025, and recent corporate highlights. Third Quarter 2025 Financial Results   Quarter Ended September 30, 2025 Total revenue $197 million GAAP gross margin 70% Non-GAAP gross margin 70% GAAP operating expenses $153 million Non-GAAP operating ex

    10/30/25 4:05:00 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    ATEC to Report Third Quarter 2025 Financial Results on October 30, 2025

    Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report third quarter 2025 financial results on October 30, 2025, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations section of ATEC's corporate website. Dial-In To dial into the live webcast, please register at this link. Access details will be provided via email. Replay A replay of the webcast will remain available through the Investor Relations section of ATEC's corporate website for twelve month

    10/16/25 4:10:00 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Rydin Jeffrey P sold $3,864,000 worth of shares (200,000 units at $19.32), decreasing direct ownership by 34% to 385,441 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    11/5/25 6:30:07 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    CEO Miles Patrick sold $1,896,000 worth of shares (100,000 units at $18.96), decreasing direct ownership by 2% to 5,364,078 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    11/5/25 6:30:05 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    EVP, PEOPLE & CULTURE Hunsaker Craig E sold $1,995,000 worth of shares (100,000 units at $19.95), decreasing direct ownership by 7% to 1,289,142 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    10/31/25 6:30:05 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    SEC Filings

    View All

    Alphatec Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Alphatec Holdings, Inc. (0001350653) (Filer)

    11/7/25 9:10:27 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    SEC Form 144 filed by Alphatec Holdings Inc.

    144 - Alphatec Holdings, Inc. (0001350653) (Subject)

    11/4/25 4:29:53 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by Alphatec Holdings Inc.

    10-Q - Alphatec Holdings, Inc. (0001350653) (Filer)

    10/30/25 4:57:18 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bakst Evan bought $201,600 worth of shares (35,000 units at $5.76) (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/26/24 4:32:07 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Director Pelizzon David R bought $149,998 worth of shares (25,796 units at $5.81), increasing direct ownership by 8% to 331,696 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/26/24 4:27:25 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Director Demski David M bought $283,500 worth of shares (50,000 units at $5.67), increasing direct ownership by 21% to 288,441 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/21/24 10:00:00 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Stifel resumed coverage on Alphatec with a new price target

    Stifel resumed coverage of Alphatec with a rating of Buy and set a new price target of $20.00

    10/28/25 7:09:19 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Analyst initiated coverage on Alphatec with a new price target

    Analyst initiated coverage of Alphatec with a rating of Overweight and set a new price target of $19.00

    10/24/25 8:59:42 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Lake Street resumed coverage on Alphatec with a new price target

    Lake Street resumed coverage of Alphatec with a rating of Buy and set a new price target of $18.00

    6/16/25 8:53:19 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    Financials

    Live finance-specific insights

    View All

    ATEC to Report Third Quarter 2025 Financial Results on October 30, 2025

    Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report third quarter 2025 financial results on October 30, 2025, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations section of ATEC's corporate website. Dial-In To dial into the live webcast, please register at this link. Access details will be provided via email. Replay A replay of the webcast will remain available through the Investor Relations section of ATEC's corporate website for twelve month

    10/16/25 4:10:00 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    ATEC to Report Second Quarter 2025 Financial Results on July 31, 2025

    Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2025 financial results on July 31, 2025, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-In To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months.

    7/17/25 9:05:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    ATEC to Report First Quarter 2025 Financial Results on May 1, 2025

    Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report first quarter 2025 financial results on May 1, 2025, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-In To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months. Inducemen

    4/14/25 9:00:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    Leadership Updates

    Live Leadership Updates

    View All

    ATEC Mourns Passing of Board Member Jeffrey P. Rydin

    Alphatec Holdings, Inc. (NASDAQ:ATEC) ("ATEC"), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced with great sadness that Jeffrey P. Rydin, a valued member of its Board of Directors, has passed away at age 59, following a lengthy illness. Mr. Rydin enjoyed nearly three decades of experience in the medical device and healthcare industries, including senior sales leadership roles at Ellipse Technologies, Inc., NuVasive, Inc., and DePuy Spine, Inc. He was one of the earliest to join the ATEC turnaround effort, coming to the Company as a Special Advisor to the Board in September 2016, in which capacity he drove many of the early deci

    11/7/25 9:05:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Paragon 28 Appoints Dave Demski to Board of Directors

    Paragon 28, Inc. (NYSE:FNA), (the "Company") a leader in foot and ankle surgical solutions, today announced the appointment of Dave Demski to serve as an independent director of the Company, effective immediately. Mr. Demski brings a wealth of global orthopedic expertise, with over two decades of executive leadership experience. With the addition of Mr. Demski, the Company increased the size of its Board of Directors from eight members to nine members and has further strengthened its strategic oversight and governance capabilities. Mr. Demski most recently served as the President and CEO of Globus Medical from August 2017 to April 2022, guiding the organization through a period of signifi

    12/11/24 9:00:00 AM ET
    $ATEC
    $FNA
    Medical/Dental Instruments
    Health Care

    Spineology® Appoints new Member to Leadership Team; Spine Veteran Emory Rooney joins as Executive Vice President of Sales

    Spineology Inc. ("Spineology" or the "Company"), the leader in ultra-minimally invasive spine surgery, announced today the addition of Emory Rooney as Executive Vice President, Sales. In this role, Rooney will lead U.S. market growth and sales efforts. Rooney comes to Spineology with extensive spine sales experience, having served in Medical Device fields related to spinal implants and navigation for nearly 20 years. "The addition of Emory adds even further conviction about our clear opportunity for growth at Spineology," said Brian Snider, Chief Executive Officer at Spineology. "I have had the opportunity to work with Emory and have seen his impact leading sales teams, building new terri

    4/4/24 9:05:00 AM ET
    $ATEC
    $SYK
    Medical/Dental Instruments
    Health Care

    $ATEC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Alphatec Holdings Inc.

    SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)

    11/12/24 8:04:57 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D/A filed by Alphatec Holdings Inc. (Amendment)

    SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)

    3/22/24 7:57:56 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D/A filed by Alphatec Holdings Inc. (Amendment)

    SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)

    5/12/23 4:51:18 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care